U.S. Markets open in 13 hrs, 59 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 44.25 09:30 AM EST | |
|---|---|---|
| Day High | 45.02 03:37 PM EST |
|
| Range | 0.77 |
| Volume | 2.04 M | |
|---|---|---|
| 30-Day Avg Vol | 1.55 M |
|
| Difference | 31.25% |
| Market Cap | 65.13 B | |
|---|---|---|
| Mkt Cap Chg | 72.40 M |
| Shares Out | 1.44 B | |
|---|---|---|
| % Shrs Traded | 0.14% | |
| 1yr EPS Est | 5.835 |
| 52-Wk Low | 29.96 | |
|---|---|---|
| 52-Wk High | 47.61 |
|
| Range | 17.65 |
| Prev Close | 44.93 11/5/09 | |
|---|---|---|
| Today's Open | 44.28 | |
| Change | -1.45% |
| Dividend (TTM) | 2.09 | |
|---|---|---|
| Div Yield (TTM) | 4.65% | |
| Ex-Div Date | 08/05/2009 | |
| Div Date | 09/14/2009 |
|
| Short Interest | 5.25 M |
| Revenue (LFY) | 31.60 B | |
|---|---|---|
| Earnings (LFY) | 6.10 B | |
| Earnings (MRQ) | 2.23 B | |
| Next Earn Est | 1.385 | |
| Next Earnings | 10/28/2010 |
|
| EPS (TTM) | 4.84233 | |
| 1yr EPS Growth | -5.12% |
| P/E Ratio (TTM) | 10.71 | |
|---|---|---|
| P/E Ratio (Fwd) | 7.70 | |
| PEG Ratio | -3.02 | |
| Return on Equity | 39.74 | |
| Beta | 0.63 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
AstraZeneca's products run the gamut from A (breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's top pharmaceutical firms, AstraZeneca specializes in drugs for gastrointestinal, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 1.385 10/29/09 | — — |
—
—
|
| Last Quarter | 1.385 9/30/09 | 1.68 9/30/09 |
0.295
Beat
|
| 2 Quarters Ago | 1.403 6/30/09 | 1.64 6/30/09 |
0.237
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 8.66 B | 31.60 B |
| Gross Profit | 7.35 B | 24.88 B |
| Operating Income | 3.44 B | 10.02 B |
| Net Income | 2.23 B | 6.10 B |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts